174 related articles for article (PubMed ID: 31358902)
1. Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer.
Han X; Ren C; Yang T; Qiao P; Wang L; Jiang A; Meng Y; Liu Z; Du Y; Yu Z
Oncogene; 2019 Sep; 38(38):6537-6549. PubMed ID: 31358902
[TBL] [Abstract][Full Text] [Related]
2. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
3. Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer.
Lu C; Qiao P; Sun Y; Ren C; Yu Z
Clin Transl Med; 2021 Apr; 11(4):e400. PubMed ID: 33931981
[TBL] [Abstract][Full Text] [Related]
4. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells.
Yu Z; Zhao X; Huang L; Zhang T; Yang F; Xie L; Song S; Miao P; Zhao L; Sun X; Liu J; Huang G
J Biol Chem; 2013 Dec; 288(49):35406-16. PubMed ID: 24142698
[TBL] [Abstract][Full Text] [Related]
5. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
Yang T; Ren C; Qiao P; Han X; Wang L; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Oncogene; 2018 Nov; 37(45):5997-6009. PubMed ID: 29985480
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.
Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z
Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
8. Proviral insertion in murine lymphomas 2 promotes stomach cancer progression by regulating apoptosis via reactive oxygen species-triggered endoplasmic reticulum stress.
Xin H; Deng Y; Cao J
Biochem Biophys Res Commun; 2018 Nov; 506(1):145-152. PubMed ID: 30340823
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis.
Lu C; Qiao P; Fu R; Wang Y; Lu J; Ling X; Liu L; Sun Y; Ren C; Yu Z
Cell Death Dis; 2022 Sep; 13(9):790. PubMed ID: 36109523
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression.
Kronschnabl P; Grünweller A; Hartmann RK; Aigner A; Weirauch U
Int J Oncol; 2020 Feb; 56(2):448-459. PubMed ID: 31894300
[TBL] [Abstract][Full Text] [Related]
11. PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis.
Wang M; Fan R; Jiang J; Sun F; Sun Y; Wang Q; Jiang A; Yu Z; Yang T
Reprod Sci; 2023 Sep; 30(9):2692-2702. PubMed ID: 37059967
[TBL] [Abstract][Full Text] [Related]
12. Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.
Lu J; Zavorotinskaya T; Dai Y; Niu XH; Castillo J; Sim J; Yu J; Wang Y; Langowski JL; Holash J; Shannon K; Garcia PD
Blood; 2013 Aug; 122(9):1610-20. PubMed ID: 23818547
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase regulates cancer cell growth and metabolism via nuclear and mitochondria events.
Jiang S; Wang Y; Luo L; Shi F; Zou J; Lin H; Ying Y; Luo Y; Zhan Z; Liu P; Zhu B; Huang D; Luo Z
J Cell Mol Med; 2019 Jun; 23(6):3951-3961. PubMed ID: 30993829
[TBL] [Abstract][Full Text] [Related]
14. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
15. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation.
Lee YK; Lee WS; Kim GS; Park OJ
Oncol Rep; 2010 Dec; 24(6):1471-7. PubMed ID: 21042741
[TBL] [Abstract][Full Text] [Related]
16. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
17. PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.
Musiani D; Hammond DE; Cirillo L; Erriquez J; Olivero M; Clague MJ; Di Renzo MF
J Proteome Res; 2014 Nov; 13(11):4970-82. PubMed ID: 25099161
[TBL] [Abstract][Full Text] [Related]
18. Role of PIM2 in allergic asthma.
Du W; Chen T; Ni Y; Hou X; Yu Y; Zhou Q; Wu F; Tang W; Shi G
Mol Med Rep; 2017 Nov; 16(5):7504-7512. PubMed ID: 28944837
[TBL] [Abstract][Full Text] [Related]
19. AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation.
Wang YN; Lu YX; Liu J; Jin Y; Bi HC; Zhao Q; Liu ZX; Li YQ; Hu JJ; Sheng H; Jiang YM; Zhang C; Tian F; Chen Y; Pan ZZ; Chen G; Zeng ZL; Liu KY; Ogasawara M; Yun JP; Ju HQ; Feng JX; Xie D; Gao S; Jia WH; Kopetz S; Xu RH; Wang F
Oncogene; 2020 Jan; 39(3):637-650. PubMed ID: 31530934
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.
Nair JR; Caserta J; Belko K; Howell T; Fetterly G; Baldino C; Lee KP
Leukemia; 2017 Aug; 31(8):1715-1726. PubMed ID: 28008178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]